Prognostic Factors and Prognostic Score of Relapsed Hodgkin's Lymphoma

被引：0
|
作者：
Filatova, L. V. [1 ]
Tarasenkova, A. A. [1 ]
Gershanovich, M. L. [1 ]
Semiglazova, T. Y. [1 ]
机构：
[1] NN Petrov Res Inst Oncol, St Petersburg, Russia
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71745-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1149
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [21] High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors
    Cocorocchio, E.
    Peccatori, F.
    Vanazzi, A.
    Piperno, G.
    Calabrese, L.
    Botteri, E.
    Travaini, L.
    Preda, L.
    Martinelli, G.
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (01) : 34 - 40
  • [22] A prognostic score for advanced Hodgkin's disease
    Hasenclever, D
    Diehl, V
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1506 - 1514
  • [23] Prognostic factors in Hodgkin's disease
    Provencio, M
    España, P
    Millán, I
    Yebra, M
    Sánchez, AC
    de la Torre, A
    Bonilla, F
    Regueiro, CA
    DE Letona, JML
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1133 - 1139
  • [24] Hodgkin lymphoma: Prognostic factors and new response criteria
    Cerny, T.
    Hitz, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 115 - 116
  • [25] Prognostic factors in elderly patients with classical Hodgkin Lymphoma
    Fehr, M.
    Gusewell, S.
    Aeppli, S.
    Moccia, A.
    Bargetzi, M.
    Caspar, C.
    Brulisauer, D. M. A.
    Ebnother, M.
    Fischer, N.
    Ghilardi, G.
    Krasniqui, F.
    Lang, N.
    Mey, U.
    Mingrone, W.
    Novak, U.
    Richter, P.
    Rutti, M.
    Schmidt, A.
    Stenner, F.
    Voegeli, M.
    Zander, T.
    Hitz, F.
    Templeton, A. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 88 - 88
  • [26] Evaluation of Hodgkin lymphoma cases and determination of prognostic factors
    Seker, Mesut
    Mengi, Alperen
    Bilici, Ahmet
    Ustaalioglu, Bala Basak
    Kefeli, Umut
    Ozseker, Naciye Isik
    Mayadagli, Alparslan
    Salepci, Taflan
    Gumus, Mahmut
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2011, 26 (03): : 108 - 114
  • [27] Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
    Guisado-Vasco, Pablo
    Arranz-Saez, Reyes
    Canales, Miguel
    Canovas, Araceli
    Garcia-Larana, Jose
    Garcia-Sanz, Ramon
    Lopez, Andres
    Luis Lopez, Jose
    Llanos, Marta
    Maria Moraleda, Jose
    Rodriguez, Jose
    Rayon, Consuelo
    Sabin, Pilar
    Salar, Antonio
    Marin-Niebla, Ana
    Morente, Manuel
    Sanchez-Godoy, Pedro
    Francisco Tomas, Jose
    Muriel, Alfonso
    Abraira, Victor
    Piris, Miguel A.
    Garcia, Juan F.
    Montalban, Carlos
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 812 - 819
  • [28] Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease
    Josting, A
    Engert, A
    Diehl, V
    Canellos, GP
    ANNALS OF ONCOLOGY, 2002, 13 : 112 - 116
  • [29] Determination of prognostic factors in 18F-FDG PET/CT of relapsed/refractory Hodgkin lymphoma
    Jajroudi, M.
    Geramifar, P.
    Eslami, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1908 - S1909
  • [30] The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed hodgkin lymphoma
    Atas, Erman
    Kesik, Vural
    Babacan, Oguzhan
    Korkmazer, Nadir
    Akyuz, Canan
    PEDIATRIC TRANSPLANTATION, 2015, 19 (04) : 380 - 384
12345